Financials
- Market Capitalization 113.53 M
- Employee 8
- Founded 2020
- CEO N/A
- Website www.coyatherapeutics.com
- Headquarter Delaware, United States
- FIGI BBG00Z4HBCB9
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-3.43
Relación precio/flujo de caja
8.37
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 3922 | CUE Cue Biopharma, Inc. - Common Stock | 28.49 USD | -8.92% | -19.36% | +19.01% | +3251.76% | 115.26 M USD | ||
| 3927 | KLRS Kalaris Therapeutics, Inc. - Common Stock | 4.82 USD | +5.93% | +1.90% | +5.93% | -52.88% | 114.68 M USD | ||
| 3953 | ONCY Oncolytics Biotech Inc. - Common Stock | 0.90 USD | -1.10% | +12.50% | -6.25% | -30.23% | 107.42 M USD | ||
| 3966 | BDTX Black Diamond Therapeutics, Inc. - Common Stock | 1.81 USD | -2.69% | -5.73% | +6.47% | -40.85% | 103.72 M USD |